Busse Hospital Disposables Recalls Convenience Kits with Swab Products
Busse Hospital Disposables is recalling Convenience kits containing swab products due to uncertainty about manufacturing validation adequacy. The kits were distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall involving products used in medical and drug applications. Although no illnesses or injuries have been reported, the validation uncertainty means manufacturing defects have not been ruled out, qualifying this as a risk-of-harm product situation where injury has not yet been reported.
Plain-English summary
Busse Hospital Disposables, Inc. is recalling Busse Convenience kits that contain swab/swabstick drug products manufactured by Professional Disposables International. The kits have been distributed nationwide.
The recall is issued due to uncertainty regarding the adequacy of the validation of test methods used in manufacturing the products. This validation concern prevents confirmation that the manufacturing process met required standards. Lot Number 2130616 is identified by UDI 00849233006027.
Consumers who obtained the affected kits should discontinue use and consult their healthcare provider if they have questions about product exposure.
The recalled product
- Product
- Pellet Insertion Tray Catalog Number: B1654
- Manufacturer
- Busse Hospital Disposables, Inc.
- Category
- Drug
- Hazard
- manufacturing-validation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot Numbers: 2130616 UDI: 00849233006027
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27